XML 116 R103.htm IDEA: XBRL DOCUMENT
v3.7.0.1

EQUITY METHOD INVESTMENTS (Narrative) (Details) ¥ in Thousands, $ in Thousands | 1 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 29, 2016 CNY (¥) | Sep. 29, 2016 USD ($) | Jul. 31, 2015 CNY (¥) | Dec. 31, 2016 CNY (¥) | Dec. 31, 2016 USD ($) | Dec. 31, 2015 CNY (¥) | Dec. 31, 2015 USD ($) | Dec. 31, 2014 CNY (¥) | Dec. 28, 2012 CNY (¥)
Schedule Of Results Related To Equity Accounted Investees [Line Items] |  |  |  |  |  |  |  |  |  |
Share of net profit (loss) |  |  |  |  | ¥ 616 | $ 89 | ¥ (5,572) |  | ¥ 13,911 |
Cash distribution from an equity investee |  |  |  |  | 9,357 | 1,348 | ¥ 24,316 |  | 21,984 |
Fair value of identified net asset on acquisition date |  |  |  | ¥ 19,658 |  |  |  |  |  | ¥ 73,570
Business Combination, Consideration Transferred |  | ¥ 41,670 | $ 6,002 |  | ¥ 100,000 | $ 14,403 |  |  |  |
Suzhou Chorus Medical Technologies Co., Ltd [Member] |  |  |  |  |  |  |  |  |  |
Schedule Of Results Related To Equity Accounted Investees [Line Items] |  |  |  |  |  |  |  |  |  |
Equity Method Investment, Ownership Percentage | [1] |  |  |  | 36.00% | 36.00% | 36.00% | 36.00% |  |
Business Combination, Consideration Transferred |  |  |  |  |  |  | ¥ 4,320 | $ 622 |  |
Global Oncology One, Inc [Member] |  |  |  |  |  |  |  |  |  |
Schedule Of Results Related To Equity Accounted Investees [Line Items] |  |  |  |  |  |  |  |  |  |
Equity Method Investment, Ownership Percentage | [1] |  |  |  | 46.90% | 46.90% | 46.90% | 46.90% |  |
Business Combination, Consideration Transferred |  |  |  |  |  |  | ¥ 8,679 | $ 1,250 |  |
CMSUSA [Member] |  |  |  |  |  |  |  |  |  |
Schedule Of Results Related To Equity Accounted Investees [Line Items] |  |  |  |  |  |  |  |  |  |
Equity Method Investment, Ownership Percentage |  |  |  |  |  |  | 100.00% | 100.00% |  |
PTC [Member] |  |  |  |  |  |  |  |  |  |
Schedule Of Results Related To Equity Accounted Investees [Line Items] |  |  |  |  |  |  |  |  |  |
Share of net profit (loss) |  |  |  | ¥ 34,206 |  |  |  |  |  | ¥ 107,139
Cash distribution from an equity investee |  |  |  |  | ¥ 9,357 | $ 1,348 | ¥ 24,316 |  | ¥ 18,812 |
[1] | In 2015, the Group entered into two share transfer agreements with JWYK, which was controlled by one of the Group's directors. Pursuant to the agreements, JWYK would acquired 36% equity interest in Suzhou Chorus and 100% interest in China Medstar, an oversea subsidiary of the Company who holds 46.9% equity interest in Global Oncology from the Group, at a consideration of RMB4,320 (US$622) and RMB8,679 (US$1,250) respectively. On April 25, 2016 and November 10, 2016, the Group received full payments from JWYK. As of December 31, 2016, the changes in registration of shareholders have not been completed and the consideration received was recorded in accrued expenses and other liabilities on the consolidated balance sheets (note 19).

X
- Definition Schedule Of Results Related To Equity Accounted Investees [Line Items] + References No definition available. + Details
Name: | ccm_ScheduleOfResultsRelatedToEquityAccountedInvesteesLineItems
Namespace Prefix: | ccm_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The net amount, measured at acquisition-date fair value, of all the assets acquired and liabilities assumed that arise from contingencies and were recognized by the entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (d)(1) -URI http://asc.fasb.org/extlink&oid=73530397&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=66011266&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount of net income (loss) reported by an equity method investment of the entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=64827811&loc=SL51721683-107760 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=66011266&loc=d3e33918-111571 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=66011266&loc=d3e33912-111571 + Details
Name: | us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Cash dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations that are returns of capital. Excludes dividends or distributions from equity method investments classified as operating activities. + References No definition available. + Details
Name: | us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ccm_SuzhouChorusMedicalTechnologiesCoLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ccm_GlobalOncologyOneIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ccm_CmsusaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=ccm_ProtonTherapyCentreHoustonManagementLimitedPartnersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |